LAWS STUART G, SVP & Chief Accounting Officer, subtracted 46 shares of Cardinal Health, Inc. (CAH) from its portfolio at the rate of $56.05 per share valuing $2,578 on Nov 13. The insider left behind 6,296 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Cardinal Health, Inc. (CAH) was $44.00. Currently, the 1st Resistance Point for this stock is $44.61, with a 2nd Resistance Point sitting at $45.22. Meanwhile, this company’s stock has a 1st Support Level at $43.58 and a 2nd Support Level at $43.15. Cardinal Health, Inc. (CAH) stock has gained $1.08, or 2.52%, in the past five days. In the last full month, these shares have lost -$4.85, or -9.93%. In the past three months, this stock’s price has fallen by -$3.70, or -7.76%. This year-to-date, Cardinal Health, Inc. (CAH) shares have lost -$0.60, or -1.35%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Cardinal Health, Inc. (CAH) stock, 20% of short-term indicators suggest that these shares are a “ Sell .” Meanwhile, 25% of medium-term indicators point to this stock being a “ Sell .” Looking further ahead, 100% of long-term indicators suggest that this stock is a “ Sell .”
With 298,060 K shares outstanding, this company currently has a market capitalization of $13,069,930K. Cardinal Health, Inc. (CAH) generates $136,809 M in annual sales, amounting to annual net income of $256,000 K. This stock has generated a 1-Year Total Return of -17.53%, a 3-Year Total Return of -41.73%, and a 5-year Total Return of -36.35%. This stock’s 5-Year Dividend Growth is 70.64%, with its most recent dividend valued at $0.476 per share on 03/29/19. Its Annual Dividend Yield is 4.34%, and its Annual Dividend Rate is 1.91.
In the most recently-reported fiscal quarter, which ended in Mar-19, Cardinal Health, Inc. (CAH) reported earnings of $1.59 per share. Wall Street analysts, on average, were expecting the company to report earnings of $1.43 per share, representing a 0.16 difference and 11.44% surprise. In the previous quarter ending in Dec-18, the reported earnings of $1.29 represented a 0.2 difference from the consensus estimate calling for $1.09 per share, which was a 18.59% surprise.
For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is $0.96 per share. This estimate came from a total of 7 Wall Street Analysts. Of those market experts, the high estimate was $1.13 and the low estimate was $0.91. In the year-ago quarter, Cardinal Health, Inc. (CAH) generated per-share earnings of $1.01. If the analysts are correct about the current quarter’s earnings, the growth will be -4.95% .
Turning our focus now to insider trading activity, there have been 0 purchases (0 shares in total) and 0 sale (0 shares in total) in the last 3 months. In the last 6 months, there have been 2 insider buys amounting to 15,842 shares and 2 insider sales amounting to 5,394 shares. In the past full year, 20 insider purchases were made (involving 229,888 shares) and 23 insider sell-offs equivalent to 51,211 shares.
Moving onto liquidity, Cardinal Health, Inc. (CAH) has a Current Ratio of 1.07, a Quick Ratio of 0.53 and a Cash Ratio of 0.08. Looking at this company’s capital structure, its Total Debt to Total Equity is 148.75, its Total Debt to Total Capital is 59.80, and its Total Debt to Total Assets is now 22.56. Looking even further ahead into the future, its Long-Term Debt to Equity is 132.23 and its Long-Term Debt to Total Capital is 53.16.